Abstract:Background Before the new round of healthcare reform in China, primary healthcare providers could obtain a fixed 15 % or greater mark-up of profits by prescribing and selling medicines. There were concerns that this perverse incentive was a key cause of irrational medicine use. China’s new Essential Medicines Program (EMP) was launched in 2009 as part of the national health sector reform initiatives. One of its core policies was to eliminate primary care providers’ economic incentives to overprescribe or prescribe unnecessarily expensive drugs, which were regarded as consequences of China’s traditional financing system for health institutions. Objectives The objective of the study was to measure changes in prescribing patterns in primary healthcare facilities after the removal of the economic incentives for physicians to overprescribe as a result of the implementation of the EMP. Methods A comparison design was applied to 8,258 prescriptions in 2007 and 8,278 prescriptions in 2010, from 83 primary healthcare facilities nationwide. Indicators were adopted to evaluate medicine utilization, which included overall number of medicines, average number of Western and traditional Chinese medicines, pharmaceutical expenditure per outpatient prescription, and proportion of prescriptions that contained two or more antibiotics. We further assessed the use of medicines (antibiotics, infusion, hormones, and intravenous injection) per disease-specific prescription for hypertension, diabetes, coronary artery heart disease, bronchitis, upper respiratory tract infection, and gastritis. A difference-in-difference analysis was employed to evaluate the net policy effect. Results Overall changes in indicators were not found to be statistically significant between the 2 years. The results varied for different diseases. The number of Western drugs per outpatient prescription decreased while that of traditional Chinese medicines increased. Overuse of antibiotics remained an extensive problem in the treatment of many diseases, though there was some significant improvement in certain diseases, like diabetes in rural areas. Medicine expenditure per prescription also decreased. Conclusions It seems that the removal of a perverse economic incentive alone would not lead to improvement of healthcare providers’ prescribing patterns. The rationality of the Essential Medicines List and the lack of payers’ and providers’ meaningful involvement in the development of the policy possibly contribute to the lack of significant changes in prescribing behaviors. It is suggested that China should adopt more comprehensive policies for healthcare facilities, physicians, patients, and payers, rather than just relying on economic incentives to improve rational use of medicines.

The Impact of China's National Essential Medicine System on Improving Rational Drug Use in Primary Health Care Facilities: an Empirical Study in Four Provinces.

The Impact of the National Essential Medicines Policy on Rational Drug Use in Primary Care Institutions in Jiangsu Province of China.

The Effect of Essential Medicines Programme on Rational Use of Medicines in China

Retrospective Survey of the Efficacy of Mandatory Implementation of the Essential Medicine Policy in the Primary Healthcare Setting in China: Failure to Promote the Rational Use of Antibiotics in Clinics.

Impacts of the Essential Medicine System on Rational Drug Use in Community Health Service Centers

Impact of Essential Medicine System on Rational Drug Use in Basic Medical Units in Mid-Western China

Analysis of rational prescription of medicines by village clinics: a repeated cross-sectional study of a province in eastern China

Short- and long-term impacts of the National Essential Medicines Policy on drug availability, price, and usage in a deprived rural county in southwestern China: an interrupted time series analysis across 8 years

Does Economic Incentive Matter for Rational Use of Medicine? China’s Experience from the Essential Medicines Program

Evaluation, in Three Provinces, of the Introduction and Impact of China'S National Essential Medicines Scheme

Effects of the Implementation of National Essential Drug System on Rational Use of Drugs in Community Health Service Center from Shanghai City

Effects of the National Essential Medicine System in Reducing Drug Prices: an Empirical Study in Four Chinese Provinces

Trends analysis for drug utilization in county public hospitals: a sample study of the pilot area of health care reform in China

A Survey of Availability, Price and Affordability of Essential Medicines from 2011 to 2016 in Chinese Secondary and Tertiary Hospitals

Impact of ‘Chief-Pharmacist System’ on drug expenditures and rational drug use

Availability and Use of Essential Medicines in China: Manufacturing, Supply, and Prescribing in Shandong and Gansu Provinces.

An Analysis on Rational Use and Affordability of Medicine after the Implementation of National Essential Medicines Policy and Zero Mark-up Policy in Hangzhou, China

Investigation and Survey of Essential Drugs Provision and Use in Primary Health Care Institutions from Some Areas in China

Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China

A review on implementation effects of National Essential Medicine System

Impact of the national essential medicine system upon operations of primary health institutions: an empirical study in four provinces and cities